Notch signaling pathway regulates T cell dysfunction in septic patients

Area of Science:

• Immunology
• Molecular Biology
• Critical Care Medicine

Background:

• Sepsis significantly disrupts both innate and adaptive immune responses.
• Immune dysregulation is a key factor influencing sepsis progression.
• The Notch signaling pathway is crucial for T cell modulation and differentiation.

Purpose of the Study:

• To investigate the immunoregulatory role of the Notch signaling pathway in T cells from sepsis and septic shock patients.
• To explore how Notch signaling affects T cell dysfunction in sepsis.

Main Methods:

• Recruited sepsis patients, septic shock patients, and normal controls.
• Quantified Notch receptors mRNA levels using real-time PCR.
• Measured T cell counts (CD3+, CD4+, CD8+) via flow cytometry.
• Assessed T cell transcriptional factors, cytotoxic molecules, and cytotoxicity.
• Inhibited Notch signaling using a gamma-secretase inhibitor (GSI) on purified T cells.

Main Results:

• Notch1 mRNA levels were elevated in sepsis and septic shock patients.
• CD4+ and CD8+ T cells showed dysfunction, with reduced counts and impaired functions.
• Notch inhibition by GSI enhanced Th1/Th17 differentiation in CD4+ T cells.
• GSI treatment promoted cytotoxic molecule expression and activity in CD8+ T cells.

Conclusions:

• The Notch signaling pathway contributes to T cell dysfunction in sepsis.
• Targeting Notch signaling may offer a therapeutic strategy to improve immune responses in sepsis.